A Danish registry study asked whether women who previously used hormonal contraception were more likely to fill a first semaglutide prescription later.[1] The question of whether GLP-1 drugs affect birth control comes up after treatment begins and depends on the medication. The Zepbound label includes a specific precaution for oral hormonal contraception.[2]
What the Danish registers showed
The researchers studied females aged 12 to 49 in the Danish registers from 1996 through 2023. Cases had filled a first semaglutide prescription without previously filling a prescription for a glucose-lowering drug. The study table and cohort diagram show 22,694 cases and 226,940 controls, for 249,634 participants overall. Cases were matched to ten controls born in the same year, and the median age was 37.[1]
Among participants who used one type of hormonal contraception, the adjusted hazard ratio was 1.42 (95% CI 1.34–1.51) for combined oral tablets and 1.63 (95% CI 1.46–1.82) for progestin-only intrauterine devices. The study reported an adjusted hazard ratio of 2.11 (95% CI 1.97–2.25) for its “other utilization patterns” group among participants who used multiple types.[1]
What the study could measure
Adjusting for BMI weakened the associations in the subset of 149,057 participants with BMI data from the Danish birth register. That subset and the timing of those BMI measurements limit what the analysis can tell us about weight change before semaglutide treatment.[1]